Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02336022 · ClinicalTrials.gov registry record
The Evaluation of a Noninvasive Respiratory Monitor in Pediatric Patients Undergoing General Anesthesia
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 90
- Enrollment target
NCT02336022: Completed study, sponsored by Boston Children's Hospital.
NCT02336022 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02336022 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
Pediatric postoperative patients are at increased risk for post-operative respiratory complications such as hypoventilation. There is no objective measure of early respiratory parameters that would predict respiratory compromise after surgery efficiently in pediatric patients. Current respiratory assessment in non-intubated patients relies on oximetry data, impendence respiratory rate monitor and subjective clinical assessment. Pulse oximetry has been extremely helpful in recognizing oxygen desaturations but it is a late indicator of respiratory decline. New advances in technology and digital signal processing have led to the development of an improved impedance based Respiratory Volume Monitor (RVM). The RVM (ExSpiron™, Respiratory Motion, Inc.; Waltham, MA) has been shown to provide accurate real-time, continuous, non-invasive measurements of tidal volume (TV), minute ventilation (MV) and respiratory rate (RR) mostly in adult patients. The investigators' primary hypothesis is that the non-invasive, impedance-based RVM monitor will accurately reflect TV, RR and MV in pediatric patients.
Interventions
- DEVICE Respiratory Motion Inc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-05 |
What the finished NCT02336022 record still lists
NCT02336022 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Respiratory Motion Inc is the first listed.
NCT02336022 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02336022 about?
NCT02336022 is a clinical study titled "The Evaluation of a Noninvasive Respiratory Monitor in Pediatric Patients Undergoing General Anesthesia". Pediatric postoperative patients are at increased risk for post-operative respiratory complications such as hypoventilation. There is no objective measure of early respiratory parameters that would predict respiratory compromise after surgery efficiently in pediatric patients. Current respiratory as...
What is the current status of trial NCT02336022?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2015-03. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02336022?
The interventions under investigation include: Respiratory Motion Inc (DEVICE).
Who is sponsoring clinical trial NCT02336022?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia